EUVIMEDEUVIMED entdecken
Crossref

Protective effects of arbutin against doxorubicin-induced cardiac damage

Oguzhan Birdal, Irmak Ferah Okkay, Ufuk Okkay, Cemil Bayram, Behzad Mokthare, Muhammed Sait Ertugrul, Ahmet Hacimuftuoglu, Emrah Aksakal, Yavuzer Koza, Mehmet Saygi, Huseyin Senocak

Molecular Biology Reports · 2024

DOI: 10.1007/s11033-024-09488-4 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Biology Reports, 2024. Verfasst von Oguzhan Birdal und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Faculty of Medicine, Ataturk University, Erzurum, Turkey. Hauptthemen laut MEDLINE: Antioxidants, Cardiotoxicity. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 46 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Doxorubicin is an effective antineoplastic agent but has limited clinical application because of its cumulative toxicities, including cardiotoxicity. Cardiotoxicity causes lipid peroxidation, genetic impairment, oxidative stress, inhibition of autophagy, and disruption of calcium homeostasis. Doxorubicin-induced cardiotoxicity is frequently tried to be mitigated by phytochemicals, which are derived from plants and possess antioxidant, anti-inflammatory, and anti-apoptotic properties. Arbutin, a natural antioxidant found in the leaves of the bearberry plant, has numerous pharmacological benefits, including antioxidant, anti-bacterial, anti-hyperglycemic, anti-inflammatory, and anti-tumor activity. METHODS AND RESULTS: The study involved male Wistar rats divided into three groups: a control group, a group treated with doxorubicin (20 mg/kg) to induce cardiac toxicity, a group treated with arbutin (100 mg/kg) daily for two weeks before doxorubicin administration. After treatment, plasma and heart tissue samples were collected for analysis. The samples were evaluated for oxidative stress parameters, including superoxide dismutase, malondialdehyde, and catalase, as well as for cardiac biomarkers, including CK, CK-MB, and LDH. The heart tissues were also analyzed using molecular (TNF-α, IL-1β and Caspase 3), histopathological and immunohistochemical methods (8-OHDG, 4 Hydroxynonenal, and dityrosine). The results showed that arbutin treatment was protective against doxorubicin-induced oxidative damage by increasing SOD and CAT activity and decreasing MDA level. Arbutin treatment was similarly able to reverse the inflammatory response caused by doxorubicin by reducing TNF-α and IL-1β levels and also reverse the apoptosis by decreasing caspase-3 levels. It was able to prevent doxorubicin-induced cardiac damage by reducing cardiac biomarkers CK, CK-MB and LDH levels. In addition to all these results, histopathological analyzes also show that arbutin may be beneficial against the damage caused by doxorubicin on heart tissue. CONCLUSION: The study suggests that arbutin has the potential to be used to mitigate doxorubicin-induced cardiotoxicity in cancer patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AntioxidantsCardiotoxicityHumansRatsAnimalsArbutinMyocardiumTumor Necrosis Factor-alphaRats, WistarDoxorubicinOxidative StressAnti-Inflammatory AgentsApoptosisBiomarkers

Stichwörter der Autor:innen

ApoptosisArbutinDNA/RNA damageDoxorubicinInflammationOxidative stress

Substanzen

AntioxidantsArbutinTumor Necrosis Factor-alphaDoxorubicinAnti-Inflammatory AgentsBiomarkers

Autor:innen und Institutionen

  • Department of Cardiology, Faculty of Medicine, Ataturk University, Erzurum, Turkey.
  • Department of Pharmacology, Faculty of Pharmacy, Ataturk University, Erzurum, Turkey. irmakferah@atauni.edu.tr.
  • Department of Medical Pharmacology, Faculty of Medicine, Ataturk University, Erzurum, 25100, Turkey. ufukokkay@atauni.edu.tr.
  • Department of Pharmacology and Toxicology, Faculty of Veterinary Medicine, Ataturk University, Erzurum, Turkey.
  • Department of Pathology, Faculty of Veterinary Medicine, Ataturk University, Erzurum, Turkey.
  • Institute for Cannabis Studies, Ondokuz Mayis University, Samsun, Turkey.

Zitieren

APA

Birdal, O., Ferah Okkay, I., Okkay, U., Bayram, C., Mokthare, B., Ertugrul, M. S., Hacimuftuoglu, A., Aksakal, E., Koza, Y., Saygi, M., & Senocak, H. (2024). Protective effects of arbutin against doxorubicin-induced cardiac damage. Molecular Biology Reports. https://doi.org/10.1007/s11033-024-09488-4

Vancouver

Birdal O, Ferah Okkay I, Okkay U, Bayram C, Mokthare B, Ertugrul MS, et al. Protective effects of arbutin against doxorubicin-induced cardiac damage. Molecular Biology Reports. 2024. doi:10.1007/s11033-024-09488-4

BibTeX
@article{Birdal2024,
  author = {Birdal, Oguzhan and Ferah Okkay, Irmak and Okkay, Ufuk and Bayram, Cemil and Mokthare, Behzad and Ertugrul, Muhammed Sait and Hacimuftuoglu, Ahmet and Aksakal, Emrah and Koza, Yavuzer and Saygi, Mehmet and Senocak, Huseyin},
  title = {Protective effects of arbutin against doxorubicin-induced cardiac damage},
  journal = {Molecular Biology Reports},
  year = {2024},
  doi = {10.1007/s11033-024-09488-4}
}
Kostenlos starten →